What are the reactions after taking targeted drugs for lung cancer?

Mar 17, 2023 Source: Cainiu Health
Dr. Sun Qifeng
Introduction
After taking targeted therapy drugs for lung cancer, some patients may experience side effects such as nausea, vomiting, skin itching, and liver pain. It is recommended to seek medical attention promptly if any discomfort occurs. There are various types of targeted drugs; common ones include gefitinib tablets, erlotinib hydrochloride tablets, and osimertinib mesylate tablets. These medications are irritating and may irritate the gastrointestinal mucosa after ingestion, leading to nausea and vomiting.

After taking targeted therapy drugs for lung cancer, patients may experience side effects such as nausea, vomiting, skin itching, and liver pain. It is recommended to seek timely medical evaluation when experiencing discomfort, identify the underlying cause, and receive appropriate treatment.

1. Nausea and Vomiting

There are various types of targeted drugs, including common ones such as gefitinib tablets, erlotinib hydrochloride tablets, and osimertinib mesylate tablets. These medications are irritating and can stimulate the gastrointestinal mucosa after ingestion, leading to nausea and vomiting.

2. Skin Itching

If patients do not follow medical instructions or adjust their medication dosage on their own, it may irritate the skin and mucous membranes, resulting in symptoms such as skin itching.

3. Liver Pain

Long-term use of targeted drugs increases the burden on liver and kidney function, affecting their normal operation and potentially causing liver and kidney damage, which may lead to liver pain.

In addition to the above adverse reactions, patients may also experience diarrhea, proteinuria, oral mucositis, paronychia, interstitial pneumonia, nasal bleeding, arrhythmia, and other symptoms. Patients are advised to visit the hospital promptly and adjust their medication under a doctor's guidance.

Related Articles

View All